HOWL Werewolf Therapeutics Net earnings per share growth this year

HOWL (werewolftx.com) - company brandmark

The annual net income per share history demonstrates volatility, with the parameter stabilizing at 33.40. Werewolf Therapeutics (HOWL) is developing innovative PREDATOR molecules through alliances with pharmaceutical behemoths. Management aims to create safe therapy methods by reducing treatment toxicity. The company is currently in the R&D stage, meaning the absence of sales is creating negative operating leverage.

Werewolf Therapeutics, Inc. (HOWL): Net earnings per share growth this year from 07/04/2022 to 11/12/2026

Analytical breakdowns and data insights for company werewolftx.com (HOWL)

- current quotes and average value forecast:
Market Chart Werewolf Therapeutics, Inc.|HOWL - Price Target Chart
- market capitalization data:
Market Valuation Werewolf Therapeutics, Inc.|HOWL - Total Company Value
- company book value details:
Accounting Value per Share Werewolf Therapeutics|HOWL - Company Net Assets|Market Capitalization to Book Value Ratio werewolftx.com|HOWL - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Ratio Werewolf Therapeutics|HOWL - Long-Term Debt to Equity|Current Liabilities to Capital Werewolf Therapeutics, Inc.|HOWL - Company Total Debt|Debt to Net Assets Werewolf Therapeutics, Inc.|HOWL - Company Long-Term Liabilities|Amount of Current Liabilities Werewolf Therapeutics|Intermediate Coverage Ratio werewolftx.com
- net income and valuation ratios data:
HOWL - Net Profit|Expected Net Profit Werewolf Therapeutics|HOWL - Price to Earnings Ratio|Future Price to Earnings Multiple Werewolf Therapeutics, Inc.|HOWL - PEG Multiple|EV/EBITDA Multiple Werewolf Therapeutics, Inc.|HOWL - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Werewolf Therapeutics|HOWL - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months werewolftx.com|HOWL - Net earnings per share growth this year|Expected earnings per share growth for next year Werewolf Therapeutics
Summary company analysis:HOWL (Werewolf)
Brand item of Werewolf Therapeutics

Werewolf Therapeutics (HOWL) is integrating energy-saving and filtration systems into its laboratories to comply with ESG standards. This metric measures the annual change in earnings per share, reflecting the efficiency of value generation. Analyzing this trend allows for an assessment of the business's real profitability without market noise. It is critical for investors to track this trend to minimize the risk of capital freeze. The EPS YoY percentage shift visualizes the company's fundamental growth.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year Immunocore PLC|Net earnings per share growth this year Janux Corp (JANX)|Earnings per share growth in current year Arcus Biosciences, Inc. (RCUS)|Net earnings per share growth this year zymeworks.com ZYME|Tango Therapeutics, Inc. - Net earnings per share growth this year|Earnings growth in current year Iovance Biotherapeutics Inc IOVA|IMTX - Earnings per share growth in current year|XNCR (Xencor Inc.) - Earnings per share growth this year|Compass Therapeutics (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year replimune.com (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech, Inc.)|Earnings per share increase in current year STRO|MiNK Therapeutics - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma, Inc.|ALX Oncology (ALXO) - Earnings per share growth in current year|Cue Biopharma Inc. - Earnings per share increase in current year|PDSB (PDS Biotech) - Earnings growth in current year|Earnings growth in current year Sonnet BioTherapeutics Holdings Inc.|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|NextCure Corporation (NXTC) - Earnings per share growth rate in current year|LPTX: Net earnings per share growth this year|Intensity Therapeutics (INTS) - Net earnings per share growth this year|SNSE: Earnings growth in current year|Earnings per share growth rate in current year Theriva Biologics Inc (TOVX)|Earnings per share growth in current year Gritstone bio Inc.|KA: Earnings per share increase in current year|Earnings growth in current year NEXI|TSBX - Earnings per share growth rate in current year|Vaccinex - Net earnings per share growth this year|HARP - Net earnings per share growth this year